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Characterization of 10p Deletions Suggests Two
Nonoverlapping Regions Contribute to the DiGeorge
Syndrome Phenotype
To the Editor:
DiGeorge syndrome (DGS; MIM 188400 [http://
www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/dispmim
?188400]) is a developmental-field defect characterized
by abnormalities of structures derived from the pharyn-
geal arches and pouches (for a review, see Driscoll and
Emanuel 1996). The vast majority of individuals with
DGS have been found to have deletions of chromosomal
region 22q11.2. However, a small number of patients
have been shown to have deletions of chromosome 10p,
with normal chromosome 22s (for a review, see Green-
berg et al. 1988). We report here the location and extent
of the deletion on chromosome 10, determined by means
of a combination of heterozygosity tests and FISH anal-
ysis, in five DGS patients. Our results do not support
the existence of a single, commonly deleted region on
10p in these five patients. Rather, they suggest that de-
letion of more than one region on chromosome 10p can
be associated with the DGS phenotype.
We examined the extent of the chromosome-10p de-
letions in five patients. Phenotypic characterizations of
three (GM6936, CH92-304, and CH95-199) of the five
patients were reported elsewhere, by Greenberg et al.
(1986), by Monaco et al. (1991) and Pignata et al.
(1996), and by Lipson et al. (1996), respectively. Mo-
lecular characterizations of the deletions present in
GM6936 and CH95-199 were also reported by Daw et
al. (1996). Patient CH95-199 is designated as “P3” in
Daw et al. (1996). The remaining two patients were
referred to us after their deletions were detected by
means of high-resolution cytogenetic analysis. All of the
patients exhibit at least one of the classic features of
DGS (cardiac defect, hypocalcemia, and/or immune de-
fect). Clinical findings are summarized in table 1.
We first performed heterozygosity mapping by use of
markers between loci D10S249 and D10S213. These
sequence-tagged sites (STSs) correspond roughly to the
cytogenetic location 10p15-10p12 (Chumakov et al.
1995). Three of the five patients had a single allele for
the three most distal markers, D10S249, D10S591, and
D10S189; this finding is consistent with a terminal de-
letion of 10p (table 2). The remaining two patients were
heterozygous, at loci D10S249, D10S591, and
D10S189, but had single alleles for a series of more
centromeric markers (table 2); this finding is consistent
with the presence of an interstitial deletion. As shown
in table 2, there is no marker for which all patients have
a single allele, which suggests that there is no common
region-of-deletion overlap among these five patients.
To confirm the heterozygosity-mapping results, we
performed FISH analysis on these five patients, using
YACs from the region. All YACs were from the CEPH/
Genethon megaYAC library, except 194G1, which was
isolated from the smaller-insert CEPH library. FISH
analysis confirmed and extended the results obtained
from the heterozygosity tests: there is no common region
of overlap among all five patients (fig. 1). Four of the
five patients have a common region of deletion that in-
cludes the shortest region-of-deletion overlap (SRO) de-
scribed in Daw et al. (1996). Two of these four patients,
GM6936 and CH95-199 (“P3”), were included in Daw
et al. (1996), and the other two do not narrow the SRO
further. Patient CH92-092, although without a deletion
for this SRO, does share an extensive region of deletion
with the other two patients with terminal deletions. Fur-
ther, it is possible that there is a small region-of-deletion
overlap between CH92-092 and CH92-304. The end-
points of the deletions in these two patients could not
be defined precisely because the YAC contig is not con-
tinuous from D10S1431 to D10S226. On the basis of
the results presented here, it is not possible to attribute
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Table 1
Clinical Features of Five Patients with 10p Deletions
Patient Sex
Cardiac
Defect Hypocalcemia
Immune
Defect
Cleft
Palate
Facial
Dysmorphia
Developmental
Delay Othera
CH92-092 F       Right renal hypopla-
sia, strabismus,
high arched palate
CH92-304b M       . . .
CH92-319 F      . . .c Hearing loss, short
neck, syndactyly
(digits 3 and 4),
long fingers
CH95-199d,e F       GE reflux, finger
contractures
GM6936f F g      Ureteral reflux, re-
current UTI, short
neck, mild pectus
excavatum
NOTE.—Plus sign ()  presence of the condition, and minus sign ()  absence of the condition.
a GE  gastroesophageal; UTI  urinary tract infection.
b Reported by Monaco et al. (1991).
c Patient too young to be evaluated.
d Reported by Lipson et al. (1996).
e This patient is referred to as “P3” in Daw et al. (1996).
f Reported by Greenberg et al. (1986).
g Probable pulmonic branch stenosis.
Table 2
Results of Heterozygosity Tests
PATIENT
MARKER (POSITION)
D10S249
(0 cM)
D10S591
(12.3 cM)
D10S189
(17.3 cM)
D10S1431 D10S226
(26.2 cM)
D10S465 D10S585
(28.9 cM)
D10S570
(32.1 cM)
D10S611 D10S213
(56.9 cM)
CH92-92 1 1 1 1 2 2 2 2 2 2
CH92-304 2 2 2 1 1 1 1 1 1 2
CH92-319 1 1 1 1 1 1 1 1 1 2
CH95-199 2 2 2 2 2 2 1 1 2 2
GM6936 1 1 1 1 1 1 1 2 2 2
NOTE.—Markers are named in order; the most distal markers are on the left. Map positions are given for those markers currently available
from the Whitehead Institute/MIT Center for Genome Research. The numbers “1” and “2” indicate the number of alleles present at a particular
locus. Markers that have been underlined are contained within the YACs shown in figure 1.
the DGS phenotype to deletions of only one interval on
chromosome 10p. Rather, these results suggest that there
are at least two regions on chromosome 10p that, when
deleted, can result in features seen in DGS.
After identification of two nonoverlapping regions of
10p loss, we screened cytogenetically normal DGS pa-
tients for submicroscopic deletions of 10p. These pa-
tients had been the subjects of molecular study and had
been shown not to have deletions of 22q11.2. Samples
for cytogenetic analysis were available from 11 patients
who had the diagnosis of DGS and no detectable deletion
of 22q11. These patients appear to have normal chro-
mosome 10s by analysis with high-resolution G-band-
ing. We performed FISH analysis on these 11 patients,
using YACs from two deleted regions on chromosome
10p. YACs 916D6 and 959B9 map to the SRO defined
by Daw et al. (1996), and YAC 944D12 maps to a sec-
ond, more telomeric locus (see fig. 1). None of the pa-
tients we examined appeared to have deletions. How-
ever, because the YACs are large, it is possible that a
small deletion within these regions would not have been
detected. When a smaller deletion interval is defined,
perhaps these patients can be reexamined.
In conclusion, we examined chromosome 10p dele-
tions in five patients diagnosed with DGS. Our results
indicate that there is no apparent common region of
overlap between these five patients. Instead, these results
suggest that, in addition to the SRO reported by Daw
et al. (1996), there is a second, more telomeric region
on chromosome 10p that, when deleted, can produce a
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Figure 1 Diagram showing the regions-of-deletion overlap, as determined by the combination of heterozygosity tests and FISH analysis.
At the top of the figure are YACs that were used for FISH analysis. Two of the three YACs used for the analysis of chromosomally normal
patients, 959B9 and 916D6, are stippled, because the 10p-deletion patients were not tested with these two YACs. The STSs that are positive
for a given YAC are shown. Map positions for several of the markers are also shown (taken from Hudson et al. [1995], with supplementary
data from the Whitehead Institute/MIT Center for Genome Research, Human Genetic Mapping Project, data release 12 [July 1997]).
DGS phenotype. Alternatively, it is possible that either
CH92-092 or CH95-199, the two patients who appear
to have no region-of-deletion overlap, has a small in-
ternal deletion, rearrangement, or point mutation that
maps within the region that is deleted in the other pa-
tients. Further characterization of these patients, as well
as analysis of additional DGS patients with deletions on
chromosome 10p, will enable us to distinguish between
these possibilities. These findings also suggest that it is
premature to screen for microdeletions of 10p in DGS
patients in whom no 22q11 deletions have yet been
identified.
One interesting feature of the patients examined here
is that there is no obvious correlation between the phe-
notypic traits of the patients and the extent of the de-
letion. In particular, the patient (CH92-319) with the
largest deletion exhibits one of the less severe pheno-
types. Because of this observed variability, it is not pos-
sible to associate deletions in one region of the chro-
mosome with a particular phenotype. The lack of a
correlation between the size of a deletion and the phe-
notype is also observed in patients with deletions on
chromosome 22, and may be a characteristic of hap-
loinsufficiency disorders.
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